Document is current

Article History

Received: 10 August 2018

Accepted: 29 October 2018

First Online: 13 November 2018

Compliance with ethical standards

:

: María Chaparro has served as a speaker, or has received research or education funding from MSD, AbbVie, Hospira, Pfizer, Takeda, Janssen, Ferring, Shire Pharmaceuticals, Dr. Falk Pharma, and Tillotts Pharma. Manuel Barreiro-de Acosta has served as a speaker, has served as a consultant and advisory member for, or has received research funding from MSD, AbbVie, Hospira, Takeda, Janssen, Kern, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, Chiesi, Gebro Pharma, Otsuka Pharmaceuticals, and Tillotts Pharma. Maribel Vera has served as speaker for Pfizer and a consultant and advisory member for Kern Pharma. Iván Guerra has served as speaker for Pfizer and a consultant and advisory member for Kern Pharma. Carlos Taxonera has served as a speaker, or a consultant and advisory member for MSD, AbbVie, Hospira, Pfizer, Takeda, Janssen, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, and Gebro Pharma. Xavier Calvet has received grants for research from Abbott, MSD, Vifor fees for advisory boards form Abbott, MSD, Takeda and Vifor and has given lectures for Abbott, MSD, Takeda, Shire and Allergan. Rocío Ferreiro-Iglesias has served as a speaker for AbbVie, Shire y MSD. Javier P. Gisbert has served as a speaker, has served as a consultant and advisory member for, or has received research funding from MSD, AbbVie, Hospira, Pfizer, Kern Pharma, Biogen, Takeda, Janssen, Roche, Celgene, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, Tillotts Pharma, Chiesi, Casen Fleet, Gebro Pharma, Otsuka Pharmaceutical, Vifor Pharma. The remaining authors declare that they have no conflict of interest.